Impact of oxygen tension according to embryo stage of development: a prospective randomized study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 11 2021
Historique:
received: 31 05 2021
accepted: 08 10 2021
entrez: 17 11 2021
pubmed: 18 11 2021
medline: 29 1 2022
Statut: epublish

Résumé

Human embryo culture under 2-8% O2 is recommended by ESHRE revised guidelines for good practices in IVF labs. Nevertheless, notably due to the higher costs of embryo culture under hypoxia, some laboratories perform embryo culture under atmospheric O2 tension (around 20%). Furthermore, recent meta-analyses concluded with low evidence to a superiority of hypoxia on IVF/ICSI outcomes. Interestingly, a study on mice embryos suggested that oxidative stress (OS) might only have an adverse impact on embryos at cleavage stage. Hence, we aimed to demonstrate for the first time in human embryos that OS has a negative impact only at cleavage stage and that sequential culture conditions (5% O2 from Day 0 to Day 2/3, then «conventional» conditions at 20% O2 until blastocyst stage) might be a valuable option for human embryo culture. 773 IVF/ICSI cycles were included in this randomized clinical trial from January 2016 to April 2018. At Day 0 (D0), patients were randomized using a 1:2 allocation ratio between group A (20% O2; n = 265) and group B (5% O2; n = 508). Extended culture (EC) was performed when ≥ 5 Day 2-good-quality-embryos were available (n = 88 in group A (20% O2)). In subgroup B, 195 EC cycles were randomized again at Day 2 (using 1:1 ratio) into groups B' (5% O2 until Day 6 (n = 101)) or C (switch to 20% O2 from Day 2 to Day 6 (n = 94). Fertilization rate, cleavage-stage quality Day 2-top-quality-embryo (D2-TQE), blastocyst quality (Day 5-top-quality-blastocyst (D5-TQB) and implantation rate (IR) were compared between groups A and B (= cleavage-stage analysis), or A(20% O2), B'(5% O2) and C(5%-to-20% O2). Overall, characteristics were similar between groups A and B. Significantly higher rates of early-cleaved embryos, top-quality and good-quality embryos on Day 2 were obtained in group B compared to group A (P < 0.05). This association between oxygen tension and embryo quality at D2 was confirmed using an adjusted model (P < 0.05). Regarding blastocyst quality, culture under 20% O

Identifiants

pubmed: 34785697
doi: 10.1038/s41598-021-01488-9
pii: 10.1038/s41598-021-01488-9
pmc: PMC8595367
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

22313

Informations de copyright

© 2021. The Author(s).

Références

Reprod Biomed Online. 2008 Aug;17(2):229-36
pubmed: 18681997
Hum Reprod Update. 2016 Jan-Feb;22(1):2-22
pubmed: 26207016
J Assist Reprod Genet. 2019 Nov;36(11):2315-2324
pubmed: 31512049
Hum Reprod. 2016 Apr;31(4):685-6
pubmed: 26908842
Hum Reprod. 2016 Oct;31(10):2245-54
pubmed: 27591227
Biol Reprod. 2012 Jul 26;87(1):24, 1-8
pubmed: 22553221
Bioessays. 2002 Sep;24(9):845-9
pubmed: 12210521
J Reprod Fertil. 1965 Feb;9:99-102
pubmed: 14257722
Fertil Steril. 2009 Apr;91(4 Suppl):1459-61
pubmed: 18722608
Fertil Steril. 2008 Jun;89(6):1677-84
pubmed: 18068162
Reprod Biomed Online. 2007 Mar;14(3):294-9
pubmed: 17359580
J Reprod Fertil. 1993 Nov;99(2):673-9
pubmed: 8107053
Hum Reprod Open. 2020 Jan 22;2020(1):hoz036
pubmed: 31989044
J Assist Reprod Genet. 2013 Aug;30(8):1073-9
pubmed: 23835722
Zygote. 2019 Jun;27(3):131-136
pubmed: 31072414
Curr Opin Obstet Gynecol. 1999 Jun;11(3):307-11
pubmed: 10369209
Fertil Steril. 2010 Jul;94(2):511-9
pubmed: 19409544
Fertil Steril. 2007 Jan;87(1):213-6
pubmed: 17081523
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6191-8
pubmed: 25337269
Fertil Steril. 2016 Aug;106(2):348-353.e2
pubmed: 27143517
Fertil Steril. 2013 Mar 1;99(3):738-744.e4
pubmed: 23245683
Int J Clin Exp Med. 2015 Apr 15;8(4):6179-85
pubmed: 26131222
Hum Reprod. 2019 Feb 1;34(2):228-234
pubmed: 30576441
Fertil Steril. 2009 Jun;91(6):2461-5
pubmed: 18554591
Hum Reprod. 2014 Jun;29(6):1173-81
pubmed: 24578475
Reprod Biomed Online. 2010 Sep;21(3):402-10
pubmed: 20691637
Fertil Steril. 2018 Jun;109(6):1030-1037.e2
pubmed: 29935641
Reprod Biomed Online. 2013 Oct;27(4):353-61
pubmed: 23953585
Hum Reprod. 2010 Mar;25(3):605-12
pubmed: 20085915
Fertil Steril. 2013 Aug;100(2):402-7
pubmed: 23628109
J Assist Reprod Genet. 2016 Jul;33(7):919-27
pubmed: 27007876
J Dev Orig Health Dis. 2017 Aug;8(4):418-435
pubmed: 28610639

Auteurs

C Herbemont (C)

Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140, Bondy, France.

J Labrosse (J)

Department of Reproductive Medicine & Fertility Preservation, Hôpital Jean Verdier, 93140, Bondy, France.

B Bennani-Smires (B)

Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140, Bondy, France.

I Cedrin-Durnerin (I)

Department of Reproductive Medicine & Fertility Preservation, Hôpital Jean Verdier, 93140, Bondy, France.

M Peigne (M)

Department of Reproductive Medicine & Fertility Preservation, Hôpital Jean Verdier, 93140, Bondy, France.

N Sermondade (N)

Department of Cytogenetic and Reproductive Biology, Hôpital Tenon, 4 rue de la Chine, 75020, Paris, France.

S Sarandi (S)

Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140, Bondy, France.

A Vivot (A)

Clinical Epidemiology Unit, Hôtel Dieu, 1 Parvis Notre-Dame, 75004, Paris, France.

E Vicaut (E)

Unité de Recherche Clinique, Hôtel Lariboisière-Fernand Widal, 200 rue du Faubourg Saint Denis, 75010, Paris, France.

Z Talib (Z)

Unité de Recherche Clinique, Hôtel Lariboisière-Fernand Widal, 200 rue du Faubourg Saint Denis, 75010, Paris, France.

M Grynberg (M)

Department of Reproductive Medicine & Fertility Preservation, Hôpital Jean Verdier, 93140, Bondy, France.

C Sifer (C)

Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140, Bondy, France. christophe.sifer@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH